{
  "id": "606b6dc194d57fd87900006a",
  "type": "list",
  "question": "Which biological drugs are EMA approved for pediatric psoriasis?",
  "ideal_answer": "Currently there are three European Medicines Agency (EMA)-approved biological treatment options for pediatric psoriasis: etanercept, ustekinumab, and adalimumab.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/31514420"
  ],
  "snippets": [
    {
      "text": "Currently there are three European Medicines Agency (EMA)-approved biological treatment options for pediatric psoriasis: etanercept, ustekinumab, and adalimumab. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31514420",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "etanercept, ustekinumab, adalimumab"
}